COVID-19 diverse outcomes: Aggravated reinfection, type I interferons and antibodies
Rafael Cardoso Maciel Costa Silva, Christianne Bandeira‐Melo, Heitor Afonso Paula Neto, André M. Vale, Leonardo Holanda Travassos
Topics & Concepts
ImmunologyAsymptomaticAntibodyPandemicImmunityPopulationCytotoxic T cellMedicineCoronavirus disease 2019 (COVID-19)InterferonVirologyBiologyImmune systemDiseaseInfectious disease (medical specialty)Internal medicineEnvironmental healthIn vitroBiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesCOVID-19 epidemiological studies